Today: Omega Healthcare Investors Inc. (OHI) Receives Consensus Recommendation of “Buy” from Analysts

Today: Omega Healthcare Investors Inc. (OHI) Receives Consensus Recommendation of “Buy” from Analysts

Omega Healthcare Investors Inc. (NYSE:OHI) has received an average rating of “Buy” from the ten brokerages that are currently covering the company. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $36.95.

OHI has been the subject of a number of research reports. Jefferies Group reiterated a “buy” rating and issued a $40.00 price objective on shares of Omega Healthcare Investors in a report on Sunday, October 23rd. Zacks Investment Research lowered shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a report on Wednesday, November 2nd. TheStreet upgraded shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Friday, August 5th. BTIG Research initiated coverage on shares of Omega Healthcare Investors in a report on Thursday, August 25th. They issued a “neutral” rating for the company. Finally, Thomas Weisel reiterated a “buy” rating and issued a $35.85 price objective on shares of Omega Healthcare Investors in a report on Monday, August 1st.

Shares of Omega Healthcare Investors (NYSE:OHI) traded up 0.778% during trading on Monday, hitting $29.145. 1,064,298 shares of the company’s stock were exchanged. The stock’s 50-day moving average price is $30.89 and its 200-day moving average price is $33.51. Omega Healthcare Investors has a 1-year low of $26.96 and a 1-year high of $38.09. The stock has a market cap of $5.69 billion, a PE ratio of 18.540 and a beta of 0.59.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings data on Monday, October 31st. The real estate investment trust reported $0.80 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.84 by $0.04. The business earned $224.60 million during the quarter, compared to the consensus estimate of $186.35 million. Omega Healthcare Investors had a net margin of 34.53% and a return on equity of 7.37%. The firm’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter last year, the business earned $0.79 EPS. On average, equities analysts expect that Omega Healthcare Investors will post $3.38 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 15th. Stockholders of record on Monday, October 31st were paid a $0.61 dividend. The ex-dividend date was Thursday, October 27th. This represents a $2.44 annualized dividend and a dividend yield of 8.44%. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.60. Omega Healthcare Investors’s payout ratio is currently 155.42%.

In related news, Director Bernard J. Korman acquired 100,000 shares of the stock in a transaction dated Friday, November 4th. The stock was bought at an average price of $29.29 per share, for a total transaction of $2,929,000.00. Following the purchase, the director now directly owns 774,685 shares of the company’s stock, valued at approximately $22,690,523.65. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Steven J. Insoft sold 5,500 shares of Omega Healthcare Investors stock in a transaction on Monday, September 12th. The shares were sold at an average price of $35.91, for a total transaction of $197,505.00. Following the completion of the sale, the insider now owns 419,081 shares of the company’s stock, valued at approximately $15,049,198.71. The disclosure for this sale can be found here. 4.54% of the stock is currently owned by insiders.

Several hedge funds have recently added to or reduced their stakes in OHI. Legal & General Group Plc increased its stake in Omega Healthcare Investors by 5.5% in the first quarter. Legal & General Group Plc now owns 346,500 shares of the real estate investment trust’s stock valued at $12,230,000 after buying an additional 18,175 shares during the last quarter. Metropolitan Life Insurance Co. NY increased its stake in Omega Healthcare Investors by 3.2% in the first quarter. Metropolitan Life Insurance Co. NY now owns 161,603 shares of the real estate investment trust’s stock valued at $5,705,000 after buying an additional 5,086 shares during the last quarter. Arizona State Retirement System increased its stake in Omega Healthcare Investors by 4.0% in the first quarter. Arizona State Retirement System now owns 84,875 shares of the real estate investment trust’s stock valued at $2,996,000 after buying an additional 3,300 shares during the last quarter. Royal Bank of Canada increased its stake in Omega Healthcare Investors by 22.3% in the first quarter. Royal Bank of Canada now owns 498,780 shares of the real estate investment trust’s stock valued at $17,608,000 after buying an additional 90,943 shares during the last quarter. Finally, BNP Paribas Arbitrage SA increased its stake in Omega Healthcare Investors by 203.2% in the second quarter. BNP Paribas Arbitrage SA now owns 97,633 shares of the real estate investment trust’s stock valued at $3,315,000 after buying an additional 65,436 shares during the last quarter. Institutional investors own 82.81% of the company’s stock.

Related posts

Leave a Comment